Nov 5, 2021 by Kody Kester3 Robinhood Stocks With High Dividend YieldsThese stocks boast yields of 3% to 6% and are popular among Robinhood's customers.
Nov 4, 2021 by Kody KesterMerck Receives Another Boost for Its Top-Selling DrugThe company announced it has received approval for another Keytruda indication in the E.U.
Nov 3, 2021 by Kody KesterIs This Under-the-Radar Medical Devices Stock a Buy?The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?
Nov 2, 2021 by Kody KesterA Pfizer Drug Moves Closer to Approval in Another Important IndicationThe European Union's health regulatory agency issued a positive opinion on Cibinqo as a potential eczema treatment.
Nov 2, 2021 by Kody KesterBristol Myers Squibb Just Got Some Great Regulatory NewsBristol Myers Squibb's multiple sclerosis drug Zeposia could soon be approved in the EU to treat ulcerative colitis.
Oct 30, 2021 by Kody KesterPepsiCo Isn't Losing Its FizzPepsiCo's third-quarter earnings were so strong that it raised its guidance for this year.
Oct 28, 2021 by Kody KesterIs This Steady Healthcare Stock a Buy?Johnson & Johnson beat analysts' earnings expectations in the third quarter. But does the valuation make the Dividend King a buy?
Oct 27, 2021 by Kody KesterAbbVie Takes Another Step Toward Its Post-Humira FutureSkyrizi is an important drug for AbbVie's future that could soon be approved for another indication in the E.U.
Oct 26, 2021 by Kody KesterShould You Buy This Juggernaut Asset Manager?BlackRock is the leading asset manager in the world and topped analysts' expectations in the third quarter.
Oct 25, 2021 by Kody KesterWhat Could These Clinical Results Mean for AbbVie's Shareholders?The results from phase 3 clinical trials suggest that Rinvoq could be an effective treatment for patients.
Oct 24, 2021 by Kody KesterIs It Time to Buy the Golden Arches?McDonald's recently announced a healthy dividend increase. But should you be loving it enough to buy the stock?
Oct 22, 2021 by Kody KesterShould You Buy This Mega-Cap Health Insurer Now?UnitedHealth Group's third-quarter results and valuation could make it a buy depending on your investing goals.
Oct 21, 2021 by Kody KesterCould This Be the Next Blockbuster Indication for Eli Lilly?Eli Lilly and Incyte's Olumiant could be a groundbreaking therapy for patients with alopecia areata.
Oct 19, 2021 by Kody KesterJohnson & Johnson May Not Have to Wait Long for Its Next Blockbuster VaccineThis vaccine could come from its candidate that prevents a little-known respiratory virus.
Oct 18, 2021 by Kody Kester2 Best Biotech Stocks to Buy Right NowThese dividend stocks provide sustainable and growing dividends, which are nearly triple the S&P 500's yield.
Oct 18, 2021 by Kody Kester2 Top Biotech Stocks to Buy in OctoberThese two biotech stocks trade at reasonable valuations and will turbocharge your income portfolio.
Oct 15, 2021 by Kody KesterThe Smartest Stocks to Buy With $200 Right NowThe elimination of trading commissions makes it an easier time than ever to begin investing.
Oct 14, 2021 by Kody KesterPfizer Just Scored Another Key Regulatory ApprovalPfizer's Cibinqo snagged an approval in Japan to treat patients with eczema.
Oct 13, 2021 by Kody Kester2 Top Healthcare Stocks to Buy for the Long HaulThese two blue-chip healthcare stocks can help long-term investors sleep well at night.
Oct 11, 2021 by Kody KesterHere's Why 2022 Could Be a Huge Year for GlaxoSmithKlineAnother big step in preventing HIV and AIDS has been taken and GlaxoSmithKline is at the forefront.
